London Biotech Baseimmune Closes £3.5M Funding, Eyes To Develop Future-Proof Universal Vaccines
Nov 02, 2021•over 3 years ago
Amount Raised
£3.5 Million
Round Type
seed
Description
The COVID-19 pandemic has fuelled a renaissance in vaccine research, underpinned by the creation of novel vaccine delivery systems and robust worldwide manufacturing pipelines, with the global vaccine market predicted to reach $108 billion by 2027.